Italy Lateral Flow Assays Market (2025-2030)
The Italy Lateral Flow Assays Market was valued at $178.7 Million in 2025 and projected to reach to $260.1 Million by 2030, representing a compound annual growth rate of 7.8%. Italy's lateral flow assays market is positioned for sustained growth through 2030, driven by increasing healthcare spending and modernization of diagnostic infrastructure across the country.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Italy Lateral Flow Assays Market Trends and Insights
- This represents a compound annual growth rate (CAGR) of 7.8%, reflecting Italy's increasing adoption of rapid diagnostic testing across healthcare settings.
- Italy's market is driven by rising demand for point-of-care diagnostics, particularly in infectious disease detection and chronic disease management, supported by the country's advanced healthcare infrastructure and regulatory framework. The Italian lateral flow assays market benefits from strong healthcare spending and a growing emphasis on decentralized diagnostics.
- Italy's aging population and prevalence of chronic conditions are accelerating the adoption of rapid, cost-effective testing solutions.
- Between 2025 and 2030, Italy is expected to see increased investment in diagnostic innovation and expanded distribution networks for lateral flow assay products across hospitals, clinics, and retail pharmacies..
Key Market Statistics
- CAGR (2025-2030) 7.8% CAGR
- Market Size, 2025 ~USD 178.7 Million
- Forecast, 2030 ~USD 260.1 Million
- Country Italy
Italy Lateral Flow Assays Market Overview
Market Valuation Growth :
Italy's lateral flow assays market is valued at USD 178.7 million in 2025, with projections reaching USD 260.1 million by 2030, demonstrating robust expansion in the diagnostic testing sector.
Consistent CAGR Performance :
The Italian market is growing at a CAGR of 7.8%, outpacing broader economic trends and reflecting strong healthcare sector investment in rapid diagnostic technologies.
Point-of-Care Diagnostics Adoption :
Italy is experiencing increased adoption of point-of-care lateral flow assays across hospitals, clinics, and pharmacies, driven by demand for faster, cost-effective diagnostic solutions.
Healthcare Infrastructure Modernization :
Italian healthcare facilities are upgrading diagnostic capabilities with lateral flow assays, supporting early disease detection and reducing patient wait times in clinical settings.
Italy Lateral Flow Assays Market Dynamics
- The 7.8% CAGR reflects growing adoption among Italian healthcare providers seeking rapid, reliable testing solutions for infectious diseases, cardiac markers, and other clinical applications.
- Regulatory support from Italian health authorities and integration with digital health initiatives are expected to accelerate market penetration.
- The market will benefit from rising awareness among Italian patients and healthcare professionals regarding the advantages of point-of-care testing, including reduced turnaround times and improved patient outcomes.
- Strategic partnerships between Italian diagnostic manufacturers and international players will further strengthen market expansion..
Market Ecosystem
LATERAL FLOW ASSAYS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides rapid lateral flow diagnostics through its BinaxNOW and other rapid-testing platforms, including digitally read LFA formats such as BinaxNOW Influenza A & B Card 2 for the DIGIVAL platform. | Enables rapid decentralized testing, supports objective digital interpretation, and provides results within minutes for point-of-care and other testing settings. |
 |
Develops lateral flow immunochromatographic tests for rapid diagnostics and is expanding access to large-scale LFA manufacturing through its strategic relationship with Sapphiros. Roche's SARS-CoV-2 Rapid Antigen Test 2.0 also incorporates digitally readable test identification. | Supports rapid decentralized testing, enables digital traceability of individual tests, and strengthens access to scalable LFA manufacturing capacity. |
 |
Through Abcam, provides LFA-related assay development tools, including a Universal Lateral Flow Assay Kit and antibody-conjugation technologies specifically applicable to LFA development. | Supports LFA assay development and optimization by enabling antibody labeling, conjugation with gold/fluorescent nanoparticles, and reproducible test development. |
 |
Provides the BD Veritor Plus System, combining a rapid point-of-care analyzer with lateral-flow-based assays for respiratory infections including influenza A/B, RSV and Group A Strep. | Provides rapid, objective digital results, supports decentralized testing, and enables multiple assays on a common point-of-care platform. |
 |
Offers QUICKVUE rapid lateral-flow tests and the SOFIA platform, which uses fluorescent immunoassay/lateral-flow technology for rapid point-of-care testing across infectious and other diagnostic applications. | Enables fast testing in point-of-care and laboratory settings, while SOFIA provides automated and objective interpretation to improve testing efficiency. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Key Takeaways
- Italy's lateral flow assays market is valued at USD 178.7 million in 2025 and is forecast to reach USD 260.1 million by 2030, growing at a 7.8% CAGR.
- Italy's advanced healthcare infrastructure and regulatory environment support rapid adoption of point-of-care diagnostic solutions.
- Italy's aging population and high prevalence of chronic diseases are key drivers of demand for rapid, accessible testing technologies.
- Italy's market is characterized by expanding distribution channels and increased investment in diagnostic innovation through 2030.
Lateral Flow Assays Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SEXUALLY TRANSMITTED INFECTION TESTING (Disease Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 8% from 2025 to 2030 |
| Largest Segment | KITS & REAGENTS (Product) |
| Market Size Base Year (Billions) | ~USD 8.52 (2025) |
| Revenue Forecast (Billions) | ~USD 12.52 (2030) |
| Segments Covered | Product, Application, Type, Disease Type, Technique |
Italy Lateral Flow Assays Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Kits & Reagents
- Readers
By Application
- Clinical Testing
- Drug Development & Quality Testing
- Food Safety & Environmental Testing
- Veterinary Diagnostics
By Type
- Bnp Or Nt-Probnp Testing
- Cardiac Marker Testing
- Chlamydia
- Cholesterol/Lipid Profile
- Ck-Mb Testing
- D-Dimer Testing
- Drugs Of Abuse Testing
- Fertility Testing
- Gonorrhea
- Hiv
- Hpv
- Infectious Disease Testing
- Myoglobin Testing
- Other Cardiac Marker Testing
- Other Clinical Tests
- Other Sexually Transmitted Diseases
- Pregnancy & Fertility Testing
- Pregnancy Testing
- Syphilis
- Troponin I & T Testing
By Disease Type
- Hepatitis
- Influenza
- Mosquito-Borne Diseases
- Other Infectious Diseases
- Sexually Transmitted Infection Testing
- Tuberculosis
By Technique
- Competitive Assays
- Multiplex Detection Assays
- Sandwich Assays
ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| DIAGNOSTIC LABORATORIES | 45.1 | 48.5 | 52.2 | 56.3 | 60.9 | 66.1 | 71.9 | 78.3 | 8.5 |
| HOME CARE SETTINGS | 49.7 | 53.7 | 58.1 | 63 | 68.5 | 74.7 | 81.7 | 89.4 | 9 |
| HOSPITALS & CLINICS | 86 | 91.3 | 97.1 | 103.5 | 110.6 | 118.5 | 127.2 | 136.7 | 7.1 |
| OTHER END USERS | 4.4 | 4.6 | 4.9 | 5.2 | 5.5 | 5.9 | 6.3 | 6.7 | 6.5 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 2.9 | 3 | 3.2 | 3.3 | 3.5 | 3.8 | 4 | 4.2 | 6 |
| TOTAL | 188 | 201.1 | 215.3 | 231.3 | 249 | 268.9 | 291 | 315.4 | 7.9 |
Target Audience
- Diagnostic Device Manufacturers : Italian and international manufacturers need market-specific data to assess Italy's growth potential, identify competitive gaps, and develop localized product strategies for the Italian healthcare system.
- Healthcare Facility Operators : Italian hospitals, clinics, and diagnostic centers require market insights to evaluate lateral flow assay adoption ROI, benchmark against peers, and optimize diagnostic service offerings.
- Investment & Private Equity Firms : Investors targeting Italy's healthcare sector need comprehensive market analysis to evaluate acquisition opportunities, growth potential, and risk assessment for diagnostic companies operating in Italy.
- Healthcare Policy & Government Bodies : Italian health ministry officials and regional healthcare authorities use market data to inform diagnostic infrastructure investments, reimbursement policies, and public health preparedness planning.
- Distributors & Supply Chain Partners : Italian medical device distributors and logistics providers need market forecasts to optimize inventory management, negotiate supplier agreements, and plan distribution network expansion.
Reasons to Buy this Report
- Italy-Specific Market Sizing : Access precise valuation data for Italy's lateral flow assays market with verified 2025 baseline (USD 178.7M) and 2030 forecasts, enabling accurate business planning and investment decisions.
- Competitive Landscape Intelligence : Understand Italy's unique competitive dynamics, local manufacturer strategies, and market consolidation trends specific to the Italian healthcare diagnostic sector.
- Regulatory & Reimbursement Insights : Gain detailed knowledge of Italian regulatory requirements, CE marking pathways, and reimbursement policies affecting lateral flow assay commercialization and market access.
- Growth Driver Analysis : Identify Italy-specific growth catalysts including healthcare modernization initiatives, pandemic preparedness investments, and adoption trends in Italian clinical settings.
- Strategic Market Entry Planning : Develop targeted go-to-market strategies for Italy with insights on distribution channels, key opinion leaders, and healthcare facility procurement patterns unique to the Italian market.
Frequently asked questions
What is the current size of Italy's lateral flow assays market?
Italy's lateral flow assays market was valued at USD 178.7 million in 2025.
What is the projected market size for Italy's lateral flow assays by 2030?
Italy's lateral flow assays market is projected to reach USD 260.1 million by 2030.
What is the CAGR for Italy's lateral flow assays market?
Italy's lateral flow assays market is expected to grow at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2030.
What are the main drivers of growth in Italy's lateral flow assays market?
Key drivers include Italy's aging population, rising prevalence of chronic diseases, strong healthcare spending, and increasing demand for point-of-care diagnostics.
Which applications are driving demand for lateral flow assays in Italy?
Infectious disease detection and chronic disease management are primary applications driving demand for lateral flow assays across Italy's healthcare system.
RESEARCH METHODOLOGY
The study focused on estimating the current market size of the global lateral flow assays market. Exhaustive secondary research was done to collect information on the lateral flow assays industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the lateral flow assays market.
The four steps involved in estimating the market size are:
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases, white papers, annual reports, investor presentations, SEC filings of companies, and publications from government sources [such as the US Food and Drug Administration, World Health Organization (WHO), ??Centers for Disease Control and Prevention, International Organization for Standardization (ISO), Agency for Healthcare Research and Quality] to identify and collect information for the global lateral flow assays market study. It was also used to obtain key information on players and market classification & segmentation, aligned with industry trends, down to the most granular level, along with key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and other key executives from key companies and organizations in the lateral flow assays market. Primary demand-side sources include hospitals, clinics, diagnostic laboratories, and pharmaceutical and biotechnology companies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
Note 1: Other designations include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global lateral flow assays market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. The global lateral flow assays market was split into various segments and subsegments based on:
- List of major players operating in the products market at the regional and/or country level
- Product mapping of lateral flow assay providers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from lateral flow assays (or the nearest reported business unit/product category)
- Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the global lateral flow assays market
The above data was consolidated with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Data Triangulation
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data were triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Lateral flow assays, or lateral flow immunochromatographic assays, are simple-to-use diagnostic devices to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals or contaminants in water supplies, without requiring specialized equipment.
Key Stakeholders
- Lateral flow assays Product Manufacturers
- Lateral flow assay vendors and distributors
- Hospitals
- Clinical and Diagnostic Laboratories
- ??Pharmaceutical and Biotechnological Companies
- Venture Capitalists and Investors
Report Objectives
- To define, describe, analyze, and forecast the lateral flow assays (LFA) market by product, application, technique, sample type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall lateral flow assays market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast market segment size across six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the lateral flow assays market
Company profiles
- Additional five company profiles of players operating in the lateral flow assays market
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the lateral flow assays market
Get the Full Lateral Flow Assays Market Report
Full forecast, segment splits, and company analysis for all Lateral Flow Assays Market.
- Canada Lateral Flow Assays Market
- US Lateral Flow Assays Market
- Germany Lateral Flow Assays Market
- UK Lateral Flow Assays Market
- France Lateral Flow Assays Market
- Spain Lateral Flow Assays Market
- Japan Lateral Flow Assays Market
- China Lateral Flow Assays Market
- India Lateral Flow Assays Market
- Australia Lateral Flow Assays Market
- South Korea Lateral Flow Assays Market
- Brazil Lateral Flow Assays Market
- Mexico Lateral Flow Assays Market
- Argentina Lateral Flow Assays Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
